Publicacións nas que colabora con Rafael López López (18)

2025

  1. Cáncer de vejiga

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 26, pp. 1528-1533

  2. Cáncer renal

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 26, pp. 1523-1527

  3. Protocolo diagnóstico y terapéutico de la enfermedad ósea tumoral metastásica

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 26, pp. 1552-1556

  4. Protocolo diagnóstico y terapéutico de la hipercalcemia en el paciente oncológico

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 26, pp. 1557-1561

  5. Trombosis en el paciente con cáncer

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 26, pp. 1562-1565

  6. Tumores germinales

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 26, pp. 1534-1540

2023

  1. Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

    ESMO Open, Vol. 8, Núm. 4

  2. MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles

    iScience, Vol. 26, Núm. 3

  3. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

2022

  1. Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy

    Scientific Reports, Vol. 12, Núm. 1

  2. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

    Clinical Epigenetics, Vol. 14, Núm. 1

2021

  1. Molecularly targeted therapy in metastatic CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 357-364

  2. Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study

    ESMO open, Vol. 6, Núm. 2, pp. 100090

2020

  1. Clinical significance of a microRNA signature for the identification and predicting prognosis in colorectal cancers with mucinous differentiation

    Carcinogenesis, Vol. 41, Núm. 11, pp. 1498-1506

2019

  1. Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 142, pp. 449-459

2017

  1. Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome

    APMIS

  2. Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature

    Lung Cancer, Vol. 108, pp. 217-221

2016

  1. Long-term response to nivolumab and acute renal failure in a patient with metastatic papillary renal cell carcinoma and a PD-L1 tumor expression increased with sunitinib therapy: A case report

    Frontiers in Oncology, Vol. 6, Núm. NOV